Benzodiazepines
Benzodiazepines - Related Videos
01:19
Sedatives and Hypnotics Drugs: Benzodiazepines
0 Views •
2024
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS). Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:14
CNS Depressants: Barbiturates and Benzodiazepines
0 Views •
2024
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:29
Anxiolytic Drugs: Benzodiazepines and Buspirone
0 Views •
2024
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
0 Views •
Cited by 5 •
2016
This study presents a novel device that offers an easy route to quickly provide medications and fluids in patients with limited or difficult IV access. This small-diameter device is placed in the distal third of the rectum, allowing for ongoing medication and fluids administration.
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
0 Views •
Cited by 4 •
2010
Bronchial thermoplasty is a non-drug procedure for severe persistent asthma that delivers thermal energy to the airway wall in a precisely controlled manner to reduce excessive airway smooth muscle. Reducing airway smooth muscle decreases the ability of the airways to constrict, thereby reducing the frequency of asthma attacks.
FAQs
Their effect depends on GABA being present at the GABA_A receptor. As positive allosteric modulators, benzodiazepines increase the frequency of chloride-channel opening rather than producing an independent opening action. This strengthens inhibitory signaling within the receptor system’s existing neurotransmitter context, helping explain the resulting reduction in neuronal excitability.
More frequent opening increases chloride-channel activity, which shifts signaling toward inhibition and makes neurons less excitable. In pharmacology, this receptor-level effect connects the molecular action to reduced central nervous system activity. The same inhibitory basis helps account for the class’s effects across several clinical applications supported by its mechanism.
Repeated exposure can be associated with tolerance and dependence, while reducing or stopping use can be associated with withdrawal. These outcomes matter because an initially useful response may become less predictable over time, and discontinuation may present additional management concerns. Pharmacology therefore considers both therapeutic effects and adaptation to ongoing exposure.
Rapid effects make this drug class relevant to procedural sedation and to situations requiring management of anxiety, insomnia, seizures, or muscle spasms. The choice reflects the desired clinical effect, but pharmacological planning must also account for sedation and the possibility of respiratory depression, especially when other central nervous system depressants are present.
Combining benzodiazepines with other central nervous system depressants can increase concern for sedation and respiratory depression. This interaction is important in prescribing because risk is not determined by the benzodiazepine’s intended use alone. Reviewing concurrent depressant exposure supports safer pharmacological decisions and helps researchers assess the limitations of central nervous system inhibition.
Pharmacological research seeks therapies that preserve useful efficacy while reducing risks such as tolerance, dependence, withdrawal, sedation, and respiratory depression. This goal frames benzodiazepines as a model for balancing inhibitory clinical benefits against safety limitations. Such research can inform development of therapies with improved efficacy and a lower risk burden.